202 results on '"Schoepfer, Alain M."'
Search Results
2. Endoscopic Features of Eosinophilic Esophagitis
3. Eosinophile Ösophagitis – Update 2022
4. Fluticasone Propionate Orally Disintegrating Tablet (APT-1011) for Eosinophilic Esophagitis: Randomized Controlled Trial
5. Long-Lasting Dissociation of Esophageal Eosinophilia and Symptoms After Dilation in Adults With Eosinophilic Esophagitis
6. Effectiveness and Safety of High- vs Low-Dose Swallowed Topical Steroids for Maintenance Treatment of Eosinophilic Esophagitis: A Multicenter Observational Study
7. Pediatric Patients with Eosinophilic Esophagitis and Their Parents Identify Symptoms as the Most Important Treatment Outcome.
8. Variation in Endoscopic Activity Assessment and Endoscopy Score Validation in Adults With Eosinophilic Esophagitis
9. Maintenance Treatment Of Eosinophilic Esophagitis With Swallowed Topical Steroids Alters Disease Course Over A 5-Year Follow-up Period In Adult Patients
10. RPC4046, a Monoclonal Antibody Against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis
11. Heterogeneity in Clinical, Endoscopic, and Histologic Outcome Measures and Placebo Response Rates in Clinical Trials of Eosinophilic Esophagitis: A Systematic Review
12. COVID-19 aus der Sicht der Gastroenterologie
13. Latest Insights on the Relationship Between Symptoms and Biologic Findings in Adults with Eosinophilic Esophagitis
14. Pharmacologic Treatment of Eosinophilic Esophagitis: An Update
15. The perspective of celiac disease patients on emerging treatment options and non-celiac gluten sensitivity
16. Histological Phenotyping in Eosinophilic Esophagitis: Localized Proximal Disease Is Infrequent but Associated with Less Severe Disease and Better Disease Outcome.
17. Increasing Incidence of Microscopic Colitis in a Population-Based Cohort Study in Switzerland
18. Celiac disease diagnosis still significantly delayed – Doctor's but not patients’ delay responsive for the increased total delay in women
19. Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity
20. High altitude journeys and flights are associated with an increased risk of flares in inflammatory bowel disease patients
21. Eosinophilic Esophagitis beyond Eosinophils – an Emerging Phenomenon Overlapping with Eosinophilic Esophagitis: Collegium Internationale Allergologicum (CIA) Update 2023.
22. Delay in Diagnosis of Eosinophilic Esophagitis Increases Risk for Stricture Formation in a Time-Dependent Manner
23. Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity
24. Monitoring inflammatory bowel disease activity: Clinical activity is judged to be more relevant than endoscopic severity or biomarkers
25. Predictors for subsequent need for immunosuppressive therapy in early Crohn's disease
26. Diagnostic Delay in Patients With Eosinophilic Esophagitis Has Not Changed Since the First Description 30 Years Ago: Diagnostic Delay in Eosinophilic Esophagitis.
27. Prevalence of anaemia in inflammatory bowel disease in Switzerland: A cross-sectional study in patients from private practices and university hospitals
28. Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients
29. Disease Burden and Unmet Need in Eosinophilic Esophagitis.
30. Characterization of eosinophilic esophagitis variants by clinical, histological, and molecular analyses: A cross‐sectional multi‐center study.
31. Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens
32. A Clinical Severity Index for Eosinophilic Esophagitis: Development, Consensus, and Future Directions.
33. Impact of Overweight and Obesity on Disease Outcome in the Pediatric Swiss Inflammatory Bowel Disease Cohort.
34. Accuracy of Four Fecal Assays in the Diagnosis of Colitis
35. Eosinophil Distribution in Eosinophilic Esophagitis and its Impact on Disease Activity and Response to Treatment.
36. Mo2019 CLINICAL EFFECTIVENESS AND SAFETY OF ESOPHAGEAL STRICTURE DILATION USING A NOVEL ENDOSCOPIC ATTACHMENT CAP (BOUGIECAP VERSION 2.0) IN ADULTS WITH EOSINOPHILIC ESOPHAGITIS.
37. Mo1326 SWALLOWED TOPICAL TACROLIMUS INDUCES CLINICAL AND HISTOLOGICAL REMISSION IN A SUBSET OF PATIENTS WITH SEVERE LYMPHOCYTIC ESOPHAGITIS.
38. Mo1320 CROSS-SECTIONAL AND LONGITUDINAL ANALYSES IDENTIFY NONSPECIFIC ESOPHAGITIS AS A DISTINCT INFLAMMATORY ENTITY OF THE ESOPHAGUS WITH A HIGHER FREQUENCY THAN EOSINOPHILIC ESOPHAGITIS.
39. Su1850 MISMATCH IN PHYSICIAN AND PATIENT PERCEPTION OF FECAL URGENCY AND INCONTINENCE IN INFLAMMATORY BOWEL DISEASE - RESULTS FROM THE FECAL URGENCY SURVEY.
40. Sa1292 REAL-LIFE EFFECTIVENESS OF SWALLOWED TOPICAL STEROIDS, PROTON PUMP INHIBITORS, AND ELIMINATION DIETS: RESULTS FROM THE SWISS EOSINOPHILIC ESOPHAGITIS COHORT STUDY.
41. Sa1283 MAINTENANCE TREATMENT WITH ORODISPERSIBLE BUDESONIDE IS NOT ASSOCIATED WITH CHANGES IN BONE BIOMARKERS IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE): RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, 48-WEEK TRIAL (STUDY...
42. Sa1280 JUST AN INFLAMED ESOPHAGUS? – QUALITY OF LIFE IN EOSINOPHILIC ESOPHAGITIS IS IMPAIRED SUBSTANTIALLY AND OF COMPARABLE MAGNITUDE TO MORE SYSTEMIC IMMUNE-MEDIATED CONDITIONS, INCLUDING INFLAMMATORY BOWEL DISEASE, SYSTEMIC SCLEROSIS OR...
43. Sa1261 ELEVATED MUCOSAL ALTERATIONS (EMA) – A NOVEL ENDOSCOPIC SIGN OF EOSINOPHILIC ESOPHAGITIS (EOE).
44. Therapeutic concepts in adult and paediatric eosinophilic oesophagitis
45. Impact of Diagnostic Delay on Disease Course in Pediatric- versus Adult-Onset Patients with Ulcerative Colitis: Data from the Swiss IBD Cohort.
46. Therapy Patterns and Surveillance Measures of Inflammatory Bowel Disease Patients beyond Disease-Related Hospitalization: A Claims-Based Cohort Study.
47. Development of a core outcome set for therapeutic studies in eosinophilic esophagitis (COREOS).
48. Low Mannan-Binding Lectin Serum Levels Are Associated With Complicated Crohnʼs Disease and Reactivity to Oligomannan (ASCA)
49. Systematic Review of Outcome Measures Used in Observational Studies of Adults with Eosinophilic Esophagitis.
50. Comparison of Interferon-Gamma Release Assay Versus Tuberculin Skin Test for Tuberculosis Screening in Inflammatory Bowel Disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.